Home › Trial NCT04014283
Prevention of Female Cancers by Optimization of Selenium Levels in the Organism.
- Trial IDNCT04014283
- StatusUnknown
- PhaseN/A
- Study typeInterventional
- SponsorRead-Gene S.A.
- Enrollment7000
- Start date2014-10
- ConditionsBreast Neoplasms
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.